Robert T Jensen Selected Research

Ligands

1/2019	Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
2/2017	Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.
10/2013	Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
3/2013	Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes.
8/2011	Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
9/2006	In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert T Jensen Research Topics

Disease

64	Neoplasms (Cancer) 07/2023 - 01/2002
26	Lung Neoplasms (Lung Cancer) 07/2023 - 05/2002
20	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021 - 01/2003
20	Gastrinoma 04/2021 - 01/2002
16	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 02/2023 - 02/2002
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 01/2003
11	Neoplasm Metastasis (Metastasis) 06/2017 - 07/2002
10	Carcinoid Tumor (Carcinoid) 01/2018 - 12/2002
7	Multiple Endocrine Neoplasia Type 1 01/2018 - 12/2003
7	Pancreatitis 07/2014 - 01/2005
6	Primitive Neuroectodermal Tumors (PNET) 01/2018 - 07/2012
5	Breast Neoplasms (Breast Cancer) 07/2023 - 01/2004
4	Chronic Pancreatitis 01/2017 - 12/2002
4	Hyperparathyroidism 02/2013 - 12/2003
3	Insulinoma 04/2021 - 02/2006
3	Obesity 10/2018 - 03/2013
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 01/2003
3	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 02/2016 - 12/2008
3	Hyperplasia 01/2007 - 12/2002
2	Gastroesophageal Reflux (GERD) 02/2023 - 01/2006
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 02/2011
2	Primary Hyperparathyroidism 02/2016 - 08/2013
2	Body Weight (Weight, Body) 01/2015 - 05/2010
2	Inflammation (Inflammations) 01/2013 - 02/2002
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2007 - 12/2002
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2007 - 12/2002
2	Atrophic Gastritis 01/2007 - 07/2002
2	Infections 11/2006 - 02/2002

Drug/Important Bio-Agent (IBA)

16	Peptides (Polypeptides)IBA 07/2023 - 06/2002
16	AcidsIBA 02/2023 - 01/2002
15	GastrinsIBA 10/2019 - 01/2002
14	Tyrosine (L-Tyrosine)FDA Link 07/2023 - 05/2002
14	BombesinIBA 01/2021 - 06/2002
13	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2002
12	Bombesin Receptors (Bombesin Receptor)IBA 01/2021 - 08/2003
10	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 08/2021 - 11/2002
10	bombesin receptor subtype 3IBA 01/2019 - 02/2008
9	NeurotensinIBA 07/2023 - 05/2002
9	ErbB Receptors (EGF Receptor)IBA 07/2023 - 07/2010
9	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2022 - 01/2002
9	Messenger RNA (mRNA)IBA 12/2019 - 02/2002
8	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2023 - 01/2011
8	Proton Pump InhibitorsIBA 11/2021 - 07/2002
8	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021 - 01/2003
7	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2002
7	Hormones (Hormone)IBA 04/2021 - 08/2003
6	Tyrosine Kinase InhibitorsIBA 07/2023 - 06/2012
6	LigandsIBA 01/2019 - 09/2006
6	Cholecystokinin (Pancreozymin)IBA 02/2017 - 12/2002
6	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 02/2008
6	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 09/2007 - 01/2003
5	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2021 - 03/2003
5	Secretin FDA Link 11/2021 - 08/2003
5	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2002
5	CytokinesIBA 07/2014 - 02/2002
4	Gefitinib (Iressa)FDA Link 07/2023 - 06/2012
4	NeuropeptidesIBA 01/2020 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2004
4	CalciumIBA 01/2018 - 11/2006
4	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018 - 01/2012
4	Chromogranin AIBA 06/2017 - 07/2003
4	ChemokinesIBA 02/2017 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 08/2002
3	Phosphotransferases (Kinase)IBA 07/2023 - 01/2017
3	Amino Acids FDA Link 07/2023 - 04/2002
3	Everolimus FDA Link 02/2022 - 06/2018
3	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2021 - 06/2012
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2018 - 01/2002
3	Cytotoxins (Cytolysins)IBA 01/2018 - 09/2006
3	Insulin (Novolin)FDA Link 01/2017 - 01/2015
3	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 07/2015 - 12/2002
3	Tumor Biomarkers (Tumor Markers)IBA 05/2012 - 07/2003
3	neuromedin BIBA 07/2010 - 06/2002
3	Gastrin-Releasing PeptideIBA 02/2008 - 06/2002
3	CamptothecinIBA 09/2007 - 05/2004
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2007 - 05/2004
2	SR 48692IBA 07/2023 - 03/2014
2	Trastuzumab (Herceptin)FDA Link 07/2023 - 07/2002
2	Sunitinib (Sutent)FDA Link 02/2022 - 01/2018
2	Peptide Receptors (Peptide Receptor)IBA 02/2022 - 09/2016
2	Endothelins (Endothelin)IBA 01/2021 - 01/2017
2	Neurotensin Receptors (Neurotensin Receptor)IBA 12/2019 - 05/2002
2	Type C PhospholipasesIBA 01/2019 - 01/2018
2	Growth Factor ReceptorsIBA 01/2018 - 07/2002
2	IntegrinsIBA 02/2017 - 08/2011
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2017 - 01/2014
2	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 07/2015 - 03/2013
2	Metalloproteases (Metalloproteinases)IBA 07/2015 - 08/2011
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2012 - 05/2002
2	NF-kappa B (NF-kB)IBA 01/2012 - 08/2011
2	trans-sodium crocetinate (crocetin)IBA 08/2011 - 10/2008
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2010 - 01/2006
2	IronIBA 12/2010 - 01/2006
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 05/2008 - 12/2004
2	BromidesIBA 09/2006 - 05/2004

Therapy/Procedure

17	Therapeutics 02/2022 - 08/2003
4	Parathyroidectomy 02/2016 - 12/2003
3	Drug Therapy (Chemotherapy) 02/2022 - 01/2002
3	Operative Surgical Procedures 09/2012 - 08/2003
3	Pancreaticoduodenectomy 02/2006 - 08/2003